Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
methyl salicylate + menthol + camphor
- Development stage
- Unknown
- Lead developer
- Sharif Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Bangay Ultra is a topical analgesic combination product developed and manufactured by Sharif Pharmaceuticals, a generic pharmaceutical company based in Bangladesh. The formulation contains methyl salicylate, menthol, and camphor, which work synergistically to provide temporary relief from minor aches and pains associated with arthritis, simple backache, muscle strains, and sprains. Methyl salicylate acts as a counter-irritant by inducing skin redness and warmth to distract from deeper musculoskeletal pain. Menthol provides a cooling sensation by stimulating cold-sensitive TRPM8 receptors and possesses mild local anesthetic properties. Camphor serves as a rubefacient and mild analgesic, enhancing local blood flow to the site of application by modulating various thermoreceptors including TRPV1.
- Brand names
- Bangay Ultra
- Other names
- Bangay Ultra Cream
02
Targets
TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)PGHS-1 (Prostaglandin G/H Synthase 1)TRPV3 (Transient receptor potential vanilloid subtype 3)
Beyond the preview
Go deeper on methyl salicylate + menthol + camphor.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on methyl salicylate + menthol + camphor.